Topics
Breaking Down Barriers and Forging Connectivity
There are many reasons that people dedicate their professional lives to the healthcare, pharma, ...
A Little Direction for New Creative Directors
There’s no instruction manual for leading a creative team at a marketing agency and ...
Are We Reaching the End of the Line for PBM Exclusion Lists?
In the rapidly evolving U.S. healthcare landscape, the pharmacy benefit manager (PBM) exclusion lists ...
Your Drug Landed on a Formulary Exclusion List: Where Do You Go From Here?
As a pharmaceutical marketer, you know the chance of your drug being on a ...
PM360 Q & A with Ron Caporale, CEO, Lifescript
Ron Caporale started his career at Goldman Sachs, but with an interest and background ...
Current and Future Use of HEOR Data in Decision Making
The growing power of payers in healthcare decision-making has put an increased emphasis on ...
How Pharma Companies Can Ensure They Are Getting the Most Out of HEOR
With increasing pressure on pricing and the focus on health outcomes and value-based care, ...
Using HEOR Data to Improve Healthcare Quality and Costs
As a statistician and outcomes researcher, I have supported healthcare providers and administrators in ...
Let the Doctors Drive the Conversation
For decades we’ve been used to the idea that we should craft “messages” that ...
Digital Health Interventions: Efficacy and Usability are Key
Digital health interventions (DHIs) are an established part of the healthcare landscape and are ...
Healthcare Watch August 2017
Discoveries/Innovations: T-cells Discovery Can Help Pick Best Cancer Treatments UK researchers have found that ...
Industry Briefs August 2017
Phillips-Medisize Wins Sustainability Award On World Environment Day, the Sustainability Advisory Committee and City ...
My Other Life with Davidek Herron
PM360 recently spoke to Davidek Herron, MBA, Head of Field Experience, Specialty Medicines at ...
